Unknown

Dataset Information

A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.


ABSTRACT:

Background

Bladder cancer is the second most common malignant tumor in the urogenital system. The research investigated the prognostic role of immune-related long non-coding RNA (lncRNA) in bladder cancer.

Methods

We extracted 411 bladder cancer samples from The Cancer Genome Atlas database. Single-sample gene set enrichment analysis was employed to assess the immune cell infiltration of these samples. We recognized differentially expressed lncRNAs between tumors and paracancerous tissues, and differentially expressed lncRNAs between the high and low immune cell infiltration groups. Venn diagram analysis detected differentially expressed lncRNAs that intersected the above groups. LncRNAs with prognostic significance were identified by regression analysis. Multivariate Cox an

SUBMITTER: Lai C 

PROVIDER: S-EPMC8446409 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature